See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.24▲ 0.77%
Stockholm Exchange · Sweden · Updated after 22 Oct 2026 close

Bonesupport Holding AB

BONEX · Stockholm Exchange · prices in SEK
SEK 319.80▲ +62.60 (24.34%)
Research reportHistorical data

About Bonesupport Holding AB

Bonesupport Holding AB is a Swedish medical device company based in Lund that develops injectable synthetic bone graft substitutes for orthopaedic use. Its main product family, CERAMENT, is a ceramic bone void filler that surgeons inject into bone defects, where it sets and is gradually replaced by new bone. The products are used in trauma and orthopaedic surgery, including procedures on the extremities and in infection-related bone treatment, and are sold to hospitals and specialist surgeons in several countries.

On this site Bonesupport Holding AB appears as a stock on the Stockholm Exchange (Sweden), code BONEX, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

76/ 100
Market X-Ray · price-based
Strong price profile
Ranks #100 of 912 on the Stockholm Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendStrong
90/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average47.7%
From 52-week high0.0%
MomentumStrong
75/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return53.3%
6-month return25.9%
12-month, skipping last month-16.2%
Stability (higher is calmer)Fair
53/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)53.0%
Worst drawdown, 1 year (smaller is calmer)-35.4%
LiquidityStrong
94/100
Trades actively.
See the numbers →
Avg daily value traded76.74M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
Price trend
Uptrend
Versus its 50- and 200-day averages
52-week range
165.00 – 322.20
Price is 98% of the way up
Returns
+53.3% 3m · +25.1% 1y
Price returns, dividends not included
RSI (14)
85
Overbought zone

Price chart

52-wk range 165.00 – 322.20 Daily closes, split-adjusted

Signals

50-day average230.02
200-day average216.54
Golden/death cross (60d)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)13.44

Technical summary

Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10257.3Bullish
EMA 10261.1Bullish
SMA 20241.7Bullish
EMA 20247.8Bullish
SMA 50230.0Bullish
EMA 50234.6Bullish
SMA 100224.1Bullish
EMA 100228.2Bullish
SMA 200216.5Bullish
EMA 200228.1Bullish
Oscillators (daily)
RSI (14)84.97Bearish
MACD (12, 26)14.08Bullish
Momentum (12)40.76Bullish
Stochastic %K (14)97.68Bearish
Williams %R (14)-2.32Bearish
CCI (20)287.4Bearish
Pivot points (classic, last session)
S3
238.9
S2
256.1
S1
287.9
Pivot
305.1
R1
336.9
R2
354.1
R3
385.9
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in SEK. Educational only, not financial advice.